跳至主要内容
临床试验/NCT04564365
NCT04564365Unknown不适用

Influence of Beta-Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
mortality

研究概览

简要总结

The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The diagnosis of acute myocardial infarction was clear and the left ventricular ejection fraction was normal

排除标准

  • History of heart failure Died in hospital

研究组 & 干预措施

with beta-blocker

干预措施: beta-blocker (Drug)

结局指标

主要结局

mortality

时间窗: the median time of 8 months

all-cause mortality

次要结局

未报告次要终点

研究者

发起方
Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dongying Zhang

Professor

Chongqing Medical University

研究点 (1)

Loading locations...

相似试验